Sedation or Anesthesia
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Sichuan Haisco PharmaceuticalChina - Chengdu
2 programs2
HSK3486Phase 31 trial
HSK3486Phase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Sichuan Haisco PharmaceuticalHSK3486
Sichuan Haisco PharmaceuticalHSK3486
Clinical Trials (2)
Total enrollment: 547 patients across 2 trials
A Trial Evaluating the Efficacy and Safety of HSK3486 Injectable Emulsion in Subjects Undergoing Fiberoptic Bronchoscopy
Start: Dec 2019Est. completion: Jul 2020267 patients
Phase 3Completed
A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia
Start: Oct 2018Est. completion: Mar 2019280 patients
Phase 3Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs, potential near-term approvals
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.